Influence of Ambient Temperature on Resting Energy Expenditure of Healthy Adults

April 11, 2023 updated by: Prof. Dr. Sarah Egert, University of Bonn

Influence of Ambient Temperature on Resting Energy Expenditure of Metabolically Healthy Men and Women

The aim of this study is to investigate the influence of four different ambient temperatures (18, 22, 28, 38°C) on the resting energy expenditure of healthy adults by respiratory gas analysis. It is assumed that the resting energy expenditure is higher at 18°C and 38°C than at the temperatures in between.

Study Overview

Detailed Description

In a crossover-design, 32 healthy men and women participate in four interventions. Each intervention includes a measurement of the resting energy expenditure by respiratory gas analysis at a different ambient temperature (18,22, 28 and 38°C). During this time body core- and surface temperature are assessed, as well as body composition via bioelectrical impedance analysis. For each participant the four individual study days take place in a randomized order on consecutive weekdays within a week.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bonn, Germany, 53115
        • University of Bonn

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria

  • BMI: 18,5 - 24,9 kg/m2
  • metabolically healthy

Exclusion Criteria

  • smoking
  • low or high blood pressure
  • dyslipidemia
  • insulin resistance or diabetes mellitus type 1 or type 2
  • gastrointestinal diseases (e.g. food intolerances or allergies)
  • liver, kidney and/or thyroid diseases
  • hepatitis B or C, HIV Infection
  • chronic inflammatory diseases
  • disordered eating
  • psychological diseases
  • alcohol and/or drug abuse
  • use of medication
  • pregnancy or lactating
  • participation in another intervention study
  • women: irregular menstrual cycle
  • more than 6 h of sports per week

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cold temperature
18°C
Respiratory analysis at an ambient temperature of 18°C
Experimental: Room temperature
22°C
Respiratory analysis at an ambient temperature of 22°C
Experimental: Thermoneutral temperature
28°C
Respiratory analysis at an ambient temperature of 28°C
Experimental: Hot temperature
38°C
Respiratory analysis at an ambient temperature of 38°C

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resting Energy Expenditure
Time Frame: 20 minutes
Volume of inhaled oxygen (VO2) in L/min and exhaled carbon dioxide (VCO2) in L/min
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body core temperature
Time Frame: 20 minutes
Body core temperature: assessed every ten seconds during respiratory analysis (°C)
20 minutes
Body surface temperature
Time Frame: 20 minutes
Body surface temperature: assessed every ten seconds during respiratory analysis (°C)
20 minutes
Body composition
Time Frame: 5 minutes (after respiratory analysis)
assessed daily via bioelectrical impedance analysis after respiratory analysis (FFM (kg), FM (kg))
5 minutes (after respiratory analysis)
Blood pressure
Time Frame: 10 minutes (at beginning of study day)
assessed daily before respiratory analysis (mmHg)
10 minutes (at beginning of study day)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sarah Egert, Prof. PhD, University of Bonn

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 21, 2022

Primary Completion (Actual)

April 6, 2023

Study Completion (Actual)

April 6, 2023

Study Registration Dates

First Submitted

August 15, 2022

First Submitted That Met QC Criteria

August 15, 2022

First Posted (Actual)

August 17, 2022

Study Record Updates

Last Update Posted (Actual)

April 12, 2023

Last Update Submitted That Met QC Criteria

April 11, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Resting Energy Expenditure

Clinical Trials on Respiratory analysis at cold temperature

Subscribe